Chemours (CC) PT Lowered to $14 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $13.09 --0%
Rating Summary:
7 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 12
Rating Summary:
7 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 12
Join SI Premium – FREE
RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $14.00 (from $17.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Chemours (CC) PT Lowered to $18 at Truist Securities
- Fukuda Denshi Co (6960:JP) PT Lowered to JPY9,600 at Nomura/Instinet
- Sumitomo Electric Industries Ltd (5802:JP) (SMTOY) PT Lowered to JPY2,830 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
